Olema Pharmaceuticals, Inc. Common Stock (OLMA)
Olema Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for women’s cancers. Founded to leverage innovative science, the company aims to address unmet medical needs in breast and ovarian cancers through novel approaches and personalized treatments.
Company News
Olema Oncology presented promising Phase 1b/2 trial results showing palazestrant combined with ribociclib demonstrated encouraging progression-free survival and tolerability in ER+/HER2- metastatic breast cancer patients, supporting ongoing Phase 3 clinical trials.
U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Shares of Eaton Corporation plc (NYSE: ETN) rose sharply during Thursday’s session after the company reported better-than-expected fourth-quarter financial results and issued FY24 guidance. Eaton posted adjusted earnings of $2.55 per share, beating market estima...
Olema's (OLMA) shares surge on the successful development of its lead candidate in metastatic breast cancer indication.
Watch for these 3 catalysts and consider these 6 stocks.